Back

Corporate Information History

1984-1993: Expansion Overseas of the Medical Device Business and Launch of the Pharmaceutical Business

The quality and reliability of Nipro's medical devices were highly evaluated by overseas companies, and the company started to do business with companies all over the world. In 1988, the company established its first overseas manufacturing and marketing base in Thailand, thus embarking on the globalization of its business. In addition, the company fully launched its pharmaceutical business to address increasing needs for "kits of pharmaceuticals and medical devices" in clinical settings. Thus the company established the three business pillars—medical devices, pharmaceuticals and glass—that it has maintained to this day.

1984 The company began supplying insulin injection needles to a major pharmaceutical company in Denmark.
1985 The company began supplying vacuum blood collection needles to a major medical device company in the United States. The Japan-U.S. MOSS talks promoted the manufacture of medical device kits.
1986 The company began supplying arteriovenous fistula (AVF) needles for dialysis to a major medical device company in Sweden.
1987
The company was listed on the Second Section of the Osaka Securities Exchange.
The company was listed on the Second Section of the Osaka Securities Exchange.
1988
Nissho Nipro Corporation
(currently Nipro (Thailand) Corporation Limited)
The Cellulose triacetate (CTA) dialyzer, an international commodity, was developed.
The company acquired capital in Hishiyama Pharmaceutical Corporation (current Nipro Pharma Corporation) to expand its business to pharmaceuticals.
Nisho Nipro Corporation (current Nipro (Thailand) Corporation Limited) was established in Thailand.
1990
Hishiyama Pharmaceutical Corporation Ise Plant
(currently Nipro Pharma Corporation Ise Plant)
The company was designated on the First Section of the Osaka Securities Exchange.
Hishiyama Pharmaceutical Corporation Ise Plant was constructed. A full (integrated) kit of antibiotics was developed with a major pharmaceutical manufacturer.
1991 Nisho Nipro Europe N.V. (current Nipro Europe N.V.) was established in Belgium.

Page top